In addition, elevated JAM-A expression in vulnerable versus stable atherosclerotic plaques suggests its potential as a marker of plaque instability—a critical determinant of plaque rupture and major cardiovascular complications such as myocardial infarction and stroke [13]. This evidence concerns the gene F11R and stroke disorder.